Literature DB >> 12950238

High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura.

Hatsue Ogawara1, Hiroshi Handa, Kimio Morita, Masaki Hayakawa, Junko Kojima, Hatsuo Amagai, Yuki Tsumita, Yoriaki Kaneko, Norifumi Tsukamoto, Yoshihisa Nojima, Hirokazu Murakami.   

Abstract

Chronic immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by increased platelet clearance because of antiplatelet antibodies. It was recently reported that the balance of T helper 1 (Th1) and T helper 2 (Th2) subsets has been implicated in the regulation of many immune responses. In this study, the intracellular interleukin-4 and interferon-gamma production in CD4+ T-lymphocytes activated by phorbol 12-myristate 13-acetate and ionomycin was assessed via flow cytometry in order to determine the clinical significance of the Th1/Th2 ratio in 42 patients with ITP. The study cohort included 28 untreated patients, seven postprednisolone therapy patients and seven postsplenectomy patients. The mean level of the Th1/Th2 ratio in the untreated group was 36.9 (95% CI 25.8-47.9), and significantly higher than in the control group (mean 12.8, 95% CI 9.5-16.1). The mean levels of the Th1/Th2 ratio in the postprednisolone therapy and postsplenectomy groups were 20.5 (95% CI 8.4-32.6) and 16.4 (95% CI 3.1-29.7), respectively, but were no significant differences as compared with control subjects. When untreated patients were divided into two subgroups by Th1/Th2 ratio, the mean level of platelet associated IgG in the high Th1/Th2 subgroup (higher than upper limit of control group) tended to be higher than in the normal Th1/Th2 subgroup. In conclusion, the high Th1/Th2 ratio was closely related to the etiology and disease status of chronic ITP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950238     DOI: 10.1034/j.1600-0609.2003.00138.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  41 in total

Review 1.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

2.  Bmi-1 regulates autoreactive CD4+ T cell survival in immune thrombocytopenia patients.

Authors:  Li Ma; Zeping Zhou; Donglei Zhang; Hongmei Wang; Huiyuan Li; Feng Xue; Renchi Yang
Journal:  J Clin Immunol       Date:  2012-06       Impact factor: 8.317

3.  Immune thrombocytopenia in children and adults: what's the same, what's different?

Authors:  Harald Schulze; Gerhard Gaedicke
Journal:  Haematologica       Date:  2011-12       Impact factor: 9.941

Review 4.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

5.  Fluctuations in thrombopoietin, immature platelet fraction, and glycocalicin levels in a patient with cyclic thrombocytopenia.

Authors:  Toshiaki Yujiri; Yoshinori Tanaka; Mayumi Tanaka; Yukio Tanizawa
Journal:  Int J Hematol       Date:  2009-08-29       Impact factor: 2.490

6.  Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura.

Authors:  Jin Yu; Susanne Heck; Vivek Patel; Jared Levan; Yu Yu; James B Bussel; Karina Yazdanbakhsh
Journal:  Blood       Date:  2008-04-17       Impact factor: 22.113

7.  Effects of CD70 and CD11a in immune thrombocytopenia patients.

Authors:  Li Ma; Zeping Zhou; Hairong Jia; Hu Zhou; Aiping Qi; Huiyuan Li; Hongmei Wang; Lei Zhang; Renchi Yang
Journal:  J Clin Immunol       Date:  2011-05-04       Impact factor: 8.317

8.  Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.

Authors:  Xiaodong Chen; Sirui Chen; Chunlin Li; Yankun Zhu; Bing Peng
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

9.  In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia.

Authors:  Hui Zhong; James Bussel; Karina Yazdanbakhsh
Journal:  Br J Haematol       Date:  2014-09-24       Impact factor: 6.998

10.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.